Il trattamento dell'iperparatiroidismo primitivo asintomatico: Una controversia ancora aperta

Translated title of the contribution: The management of the patient with asymptomatic primitive hyperparathyroidism: One still open controversy

Carmela Sferrazza, Daniela Avila, Nicola Napoli, Stefania Sferrazza, Giuseppe Rotolo, Giovam Battista Rini

Research output: Contribution to journalArticle

Abstract

Primitive hyperparathyroidism (pHPT) is the most common form of hyperparathyroidism. The asintomatic form (apHPT) accounts for 75-80 percent of cases and is characterized by minimal symptoms secondary to high levels of calcemia. Bisphosphonate and calciomimetic drugs represent a potential alternative to the surgery in the treatment of apHPT patients, but at the present there are not guidelines on medical therapy in the management of these kind of patients.

Translated title of the contributionThe management of the patient with asymptomatic primitive hyperparathyroidism: One still open controversy
Original languageItalian
Pages (from-to)345-348
Number of pages4
JournalRecenti Progressi in Medicina
Volume97
Issue number6
Publication statusPublished - Jun 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The management of the patient with asymptomatic primitive hyperparathyroidism: One still open controversy'. Together they form a unique fingerprint.

Cite this